FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

80959009: Methylprednisolone acetate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
134301018 Methylprednisolone acetate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
822176017 Methylprednisolone acetate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
19381000188113 méthylprednisolone acétate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
825091000172119 acétate de méthylprednisolone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Methylprednisolone acetate Is a Methylprednisolone (substance) false Inferred relationship Some
Methylprednisolone acetate Is a Acetate false Inferred relationship Some
Methylprednisolone acetate Is a Acetate compound false Inferred relationship Some
Methylprednisolone acetate Is a Pregnane (substance) true Inferred relationship Some
Methylprednisolone acetate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Methylprednisolone (substance) true Inferred relationship Some
Methylprednisolone acetate Is a Synthetic glucocorticoid false Inferred relationship Some
Methylprednisolone acetate Is a Glucocorticoid (substance) true Inferred relationship Some
Methylprednisolone acetate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance product produced by living cells that circulates in body fluids (as blood) or sap and produces a specific effect on the activity of cells usually remote from its point of origin true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Methylprednisolone acetate topical preparation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methylprednisolone acetate Inferred relationship Some
acétate de méthylprednisolone 40mg/mL, fiole de 3 mL de suspension injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methylprednisolone acetate Inferred relationship Some
acétate de méthylprednisolone 40 mg/mL, fiole de 1 mL de suspension injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methylprednisolone acetate Inferred relationship Some
acétate de méthylprednisolone 40 mg/mL, fiole de 2 mL de suspension injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methylprednisolone acetate Inferred relationship Some
Methylprednisolone acetate [musculoskeletal use] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methylprednisolone acetate Inferred relationship Some
Methylprednisolone acetate 40mg/mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methylprednisolone acetate Inferred relationship Some
Methylprednisolone acetate 80mg/mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methylprednisolone acetate Inferred relationship Some
Methylprednisolone acetate 40mg/mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methylprednisolone acetate Inferred relationship Some
Methylprednisolone acetate 40mg suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methylprednisolone acetate Inferred relationship Some
Methylprednisolone acetate 80mg/mL injection suspension 1mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methylprednisolone acetate Inferred relationship Some
Methylprednisolone acetate 40mg/mL injection suspension 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methylprednisolone acetate Inferred relationship Some
acétate de méthylprednisolone et chlorhydrate de lidocaïne 80/20 mg/2 mL pour injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methylprednisolone acetate Inferred relationship Some
acétate de méthylprednisolone et chlorhydrate de lidocaïne 40/10 mg/1 mL pour injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methylprednisolone acetate Inferred relationship Some
Product containing precisely methylprednisolone acetate 120 milligram/3 milliliter conventional release suspension for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Methylprednisolone acetate Inferred relationship Some 1
Product containing precisely methylprednisolone acetate 120 milligram/3 milliliter conventional release suspension for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Methylprednisolone acetate Inferred relationship Some 1
Product containing precisely methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Methylprednisolone acetate Inferred relationship Some 1
Product containing precisely methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Methylprednisolone acetate Inferred relationship Some 1
Product containing precisely methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Methylprednisolone acetate Inferred relationship Some 1
Product containing precisely methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Methylprednisolone acetate Inferred relationship Some 1
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Methylprednisolone acetate Inferred relationship Some 2
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Methylprednisolone acetate Inferred relationship Some 2
Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Methylprednisolone acetate Inferred relationship Some 1
Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Methylprednisolone acetate Inferred relationship Some 1
Methylprednisolone acetate 40 mg/mL suspension for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Methylprednisolone acetate Inferred relationship Some 1
Methylprednisolone acetate 40 mg/mL suspension for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Methylprednisolone acetate Inferred relationship Some 1
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Methylprednisolone acetate Inferred relationship Some 1
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Methylprednisolone acetate Inferred relationship Some 1
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Methylprednisolone acetate Inferred relationship Some 2
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Methylprednisolone acetate Inferred relationship Some 2

This concept is not in any reference sets

Back to Start